195 related articles for article (PubMed ID: 10780753)
1. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension.
Kim H; Yung GL; Marsh JJ; Konopka RG; Pedersen CA; Chiles PG; Morris TA; Channick RN
Eur Respir J; 2000 Apr; 15(4):640-8. PubMed ID: 10780753
[TBL] [Abstract][Full Text] [Related]
2. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.
Rondelet B; Kerbaul F; Motte S; van Beneden R; Remmelink M; Brimioulle S; McEntee K; Wauthy P; Salmon I; Ketelslegers JM; Naeije R
Circulation; 2003 Mar; 107(9):1329-35. PubMed ID: 12628956
[TBL] [Abstract][Full Text] [Related]
3. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.
Pearl JM; Wellmann SA; McNamara JL; Lombardi JP; Wagner CJ; Raake JL; Nelson DP
Ann Thorac Surg; 1999 Nov; 68(5):1714-21; discussion 1721-2. PubMed ID: 10585047
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor blockade in canine oleic acid-induced lung injury.
Hubloue I; Biarent D; Abdel Kafi S; Bejjani G; Mélot C; Naeije R; Leeman M
Intensive Care Med; 2003 Jun; 29(6):1003-1006. PubMed ID: 12734647
[TBL] [Abstract][Full Text] [Related]
6. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets.
Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731
[TBL] [Abstract][Full Text] [Related]
7. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
[TBL] [Abstract][Full Text] [Related]
8. Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?
Clozel M
Ann Med; 2003; 35(8):605-13. PubMed ID: 14708970
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
[TBL] [Abstract][Full Text] [Related]
10. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.
Weitzberg E; Hemsén A; Rudehill A; Modin A; Wanecek M; Lundberg JM
Br J Pharmacol; 1996 Jun; 118(3):617-26. PubMed ID: 8762086
[TBL] [Abstract][Full Text] [Related]
11. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the pulmonary arterial response to endothelin-1 and bosentan in neonatal pigs.
Domkowski PW; Cockerham JT; Kot PA; Myers JL; Hopkins RA
Ann Thorac Surg; 2000 Nov; 70(5):1522-30. PubMed ID: 11093481
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary vasoregulation by endothelin in conscious dogs after left lung transplantation.
Doi S; Smedira N; Murray PA
J Appl Physiol (1985); 2000 Jan; 88(1):210-8. PubMed ID: 10642383
[TBL] [Abstract][Full Text] [Related]
14. Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin.
Carteaux JP; Roux S; Siaghy M; Schjöth B; Dolofon P; Bechamps Y; Mertes PM; Villemot JP
Eur J Cardiothorac Surg; 1999 Mar; 15(3):346-52. PubMed ID: 10333034
[TBL] [Abstract][Full Text] [Related]
15. [Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan].
Avdeev SN
Ter Arkh; 2015; 87(9):64-71. PubMed ID: 26591555
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow.
Petrossian E; Parry AJ; Reddy VM; Akkersdijk GP; McMullan DM; Thompson L; Hendricks-Munoz KD; Hallak H; Hanley FL; Fineman JR
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):314-23. PubMed ID: 9918974
[TBL] [Abstract][Full Text] [Related]
17. The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs.
Holm P; Liska J; Clozel M; Franco-Cereceda A
J Thorac Cardiovasc Surg; 1996 Oct; 112(4):890-7. PubMed ID: 8873714
[TBL] [Abstract][Full Text] [Related]
18. Effect of bosentan on plasma endothelin-1 concentration in patients with pulmonary arterial hypertension.
Hiramoto Y; Shioyama W; Kuroda T; Masaki M; Sugiyama S; Okamoto K; Hirota H; Fujio Y; Hori M; Yamauchi-Takihara K
Circ J; 2007 Mar; 71(3):367-9. PubMed ID: 17322637
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
[TBL] [Abstract][Full Text] [Related]
20. Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries.
Milara J; Gabarda E; Juan G; Ortiz JL; Guijarro R; Martorell M; Morcillo EJ; Cortijo J
Eur Respir J; 2012 Apr; 39(4):927-38. PubMed ID: 21828025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
